Search clinical trials for: 68-Ga PSMA11
Total 673 results
-
Koo Foundation Sun Yat-Sen Cancer CenterRecruitingIndolent B-Cell Non-Hodgkin LymphomaTaiwan
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCoronary Artery DiseaseUnited States
-
UNC Lineberger Comprehensive Cancer CenterWithdrawn
-
Cellbion Co., Ltd.Recruiting
-
University of AlbertaCompleted
-
Weill Medical College of Cornell UniversityCornell UniversityNot yet recruiting
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsNot yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Jonsson Comprehensive Cancer CenterNot yet recruitingProstate Carcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
POINT BiopharmaActive, not recruitingSoft Tissue Sarcoma | Colorectal Cancer | Esophageal Cancer | Cholangiocarcinoma | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Melanoma (Skin)United States, Canada
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Recruiting
-
University of California, San FranciscoRadiological Society of North AmericaCompletedOvarian CarcinomaUnited States
-
University Health Network, TorontoNot yet recruitingAdvanced Prostate CancerCanada
-
Jules Bordet InstituteRecruitingTNBC - Triple-Negative Breast CancerBelgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMeningioma | Neuroendocrine Neoplasm | Multiple Endocrine Neoplasia Type 1 | Von Hippel-Lindau Syndrome | Metastatic Well Differentiated Neuroendocrine Neoplasm | Somatostatin Positive Neoplastic Cells PresentUnited States
-
Jonsson Comprehensive Cancer CenterCompletedRecurrent Prostate CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedRecurrence | Prostatic Neoplasms | Prostate CancerSpain, France, Switzerland, United States
-
University of Colorado, DenverCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
Michael Graham PhD, MDActive, not recruitingProstatic Neoplasms | Prostatic Neoplasms, Castration-ResistantUnited States
-
National Atomic Research Institute, TaiwanNot yet recruiting
-
Telix Pharmaceuticals (Innovations) Pty LimitedGrand Pharmaceutical (China) Co., Ltd.RecruitingProstate Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate | BCR Prostate CarcinomaChina
-
Ankara UniversityAnkara Yildirim Beyazıt University; Liv Hospital Ankara; Social Sciences University...Recruiting
-
Azienda Ospedaliero-Universitaria di ModenaRecruitingNeoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic DiseaseItaly
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
University of WashingtonNovartis; Institute for Prostate Cancer Research (IPCR)Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
University of California, San FranciscoTerminatedThyroid Gland CarcinomaUnited States
-
Thomas HopeCompletedProstate CancerUnited States
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer CenterCompletedProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Neoplasm of Uncertain BehaviorUnited States
-
Medical University of WarsawCompletedGlioma, Malignant | Glioma Glioblastoma MultiformePoland
-
University of Lausanne HospitalsCompletedProstate CancerSwitzerland
-
Andrei IagaruGeneral ElectricCompletedBreast Carcinoma | Estrogen Receptor PositiveUnited States
-
AHS Cancer Control AlbertaRecruiting
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer CenterActive, not recruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Cancer Recurrent | Prostatic Cancer MetastaticUnited States
-
Helsinki University Central HospitalUniversity of HelsinkiRecruiting
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
Sue O'DorisioNational Cancer Institute (NCI); Ride for KidsWithdrawnRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Untreated Childhood Brain Stem Glioma | Untreated Childhood Medulloblastoma | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingNeuroblastoma | Ganglioneuroblastoma | GanglioneuromaUnited States
-
University of MichiganCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
University of Michigan Rogel Cancer CenterTerminatedProstate CancerUnited States
-
Rahul AggarwalUnited States Department of DefenseCompleted
-
Tel-Aviv Sourasky Medical CenterUnknown
-
UMC UtrechtRecruitingPulmonary Embolism | Ventilation Perfusion MismatchNetherlands
-
Theragnostics LtdCompletedProstate CancerUnited Kingdom
-
Göteborg UniversityUppsala University; Sahlgrenska University Hospital, SwedenTerminated
-
Peking Union Medical College HospitalUnknown
-
Andrei IagaruGeneral ElectricCompletedProstate CancerUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedRecurrent Prostate CarcinomaUnited States
-
University of California, San FranciscoPeterson Family FoundationTerminatedNeuroendocrine Tumor | Neuroblastoma | Paraganglioma | Carcinoid TumorsUnited States
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Gilead SciencesCompletedMedullary Thyroid CarcinomaFrance
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Gilead SciencesCompletedHER2 Negative Breast Carcinoma Expressing CEAFrance